The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The group that last year claimed to have sequenced the Sasquatch genome has finally published its data in a brand new “journal,” and geneticists are not impressed.
In an upcoming hearing, the US Supreme Court will decide on whether police can take DNA samples from suspects who have not been convicted.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Harvard geneticists and anthropologists challenge the work of two economists who say there’s a link between genetic diversity and wealth.
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.